METABOLIC OXIDATION PHENOTYPES AS MARKERS FOR SUSCEPTIBILITY TO LUNG-CANCER

被引：386

作者：

AYESH, R ^{[1
]}

IDLE, JR ^{[1
]}

RITCHIE, JC ^{[1
]}

CROTHERS, MJ ^{[1
]}

HETZEL, MR ^{[1
]}

机构：

[1] ST MARYS HOSP,SCH MED,DEPT PHARMACOL,LONDON W2 1PG,ENGLAND

来源：

关键词：

D O I：

10.1038/312169a0

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：169 / 170

页数：2

共 9 条

[1] EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001
[2] A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION
EVANS, DAP
MAHGOUB, A
SLOAN, TP
IDLE, JR
SMITH, RL
[J]. JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) : 102 - 105
[3] THE GENETIC-CONTROL OF SPARTEINE AND DEBRISOQUINE METABOLISM IN MAN WITH NEW METHODS OF ANALYZING BIMODAL DISTRIBUTIONS
EVANS, DAP
HARMER, D
DOWNHAM, DY
WHIBLEY, EJ
IDLE, JR
RITCHIE, J
SMITH, RL
[J]. JOURNAL OF MEDICAL GENETICS, 1983, 20 (05) : 321 - 329
[4] METABOLISM OF [C-14]-DEBRISOQUINE IN MAN
IDLE, JR
MAHGOUB, A
ANGELO, MM
DRING, LG
LANCASTER, R
SMITH, RL
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 (03) : 257 - 266
[5] IDLE JR, BIMR CLIN PHARM THER, V2
[6] KOURI RE, 1982, CANCER RES, V42, P5030
[7] LAUTHIER P, ALCOHOLISM
[8] POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN
MAHGOUB, A
IDLE, JR
DRING, LG
LANCASTER, R
SMITH, RL
[J]. LANCET, 1977, 2 (8038) : 584 - 586
[9] SMITH RL, 1981, DRUG REACTIONS LIVER, P95